Fri, April 8, 2016
Thu, April 7, 2016
Wed, April 6, 2016
Tue, April 5, 2016
Mon, April 4, 2016

Hartaj Singh Maintained (SRPT) at Buy with Increased Target to $60 on, Apr 6th, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-60-on-apr-6th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Hartaj Singh of Oppenheimer, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $45 to $60 on, Apr 6th, 2016.

Hartaj has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Hartaj's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $15 on, Tuesday, January 19th, 2016